Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 895

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 895
---
 |  2,968 |   |     |       |  3,012 |   |
| Travel                          |     |             |                           31 |     |                |    92 |     |       |    123 |     |             |                           15 |     |                |    185 |   |     |       |    200 |   |
| Insurance and Other             |     |             |                           68 |     |                | 1,055 |     |       |  1,123 |     |             |                           58 |     |                |  1,356 |   |     |       |  1,414 |   |
| Research and development—Direct |     |             |                        4,255 |     |                |     — |     |       |  4,255 |     |             |                        6,782 |     |                |      — |   |     |       |  6,782 |   |
| Office Expenses                 |     |             |                           19 |     |                |   268 |     |       |    287 |     |             |                           51 |     |                |    323 |   |     |       |    374 |   |
| Taxes                           |     |             |                            — |     |                |     1 |     |       |      1 |     |             |                            9 |     |                |   (352 | ) |     |       |   (343 | ) |
| Depreciation                    |     |             |                            — |     |                |     — |     |       |      — |     |             |                            — |     |                |      9 |   |     |       |      9 |   |
| Total operating expenses        |     | $           |                        5,387 |     | $              | 8,145 |     | $     | 13,532 |     | $           |                        9,023 |     | $              | 12,142 |   |     | $     | 21,165 |   |

F-129

#### KINETA, INC.

### Notes to Consolidated Financial Statements

#### Entity-Wide Disclosures
In addition to the segment information, the Company provides entity-wide disclosures about its products and services, geographic areas, and major customers. The Company did not generate revenue for the year ended December 31,